Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Scholarships

University of Toronto

$17,500.00

Impact of disease-induced dysbiotic microbiota on the protective functions of innate T cells during type 1 diabetes

EF 2019-20

Résumé
"Type I diabetes (T1D) is an autoimmune disease characterized by abnormal immune responses that attack insulin-producing cells in the pancreas. In addition to genetic susceptibility, alterations in intestinal microbiota composition - called dysbiosis - have been found in children with T1D. Invariant natural killer T (iNKT) and mucosa-associated invariant T (MAIT) cells, two populations of unconventional ""innate"" T cells, play protective functions during T1D. Recent studies have suggested that the gut microbiota modulates the development and function of these T cells, leading us to hypothesize that the dysbiosis that occurs in genetically susceptible individuals impacts their immunoregulatory functions which induces a breach in tolerance and development of T1D. To address this, we will reconstitute non-obese diabetic (NOD) germ-free (no microbiota) mice with a human microbiota from diabetic and non-diabetic children. We will analyze the phenotype of iNKT and MAIT cells from various tissues such as the pancreas and pancreatic lymph nodes using flow cytometry and advanced genomic approaches. To study the impact of the microbiota on their function, these cells will be stimulated both in vivo and in vitro to analyze their production of cytokines and cytotoxic mediators. We will assess early T1D onset by analyzing immune cell infiltration within the pancreas using flow cytometry and histology, and will monitor long-term disease progression through glycemia measurements and histological pancreatic islet examination. This project will provide a greater understanding of how the interaction between the microbiota and innate T cells influences disease development and progression, and pave the way towards new strategies to manipulate iNKT and MAIT cells to control or prevent T1D."
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
428925
Name
Kuypers Meggie
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Impact of disease-induced dysbiotic microbiota on the protective functions of innate T cells during type 1 diabetes
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Dysbiosis; Fecal Transplant; Human Microbiota-Associated (Hma) Mice; Innate-Like T Lymphocytes; Invariant Natural Killer T (Inkt) Cells; Microbiota; Mucosal-Associated Invariant T (Mait) Cells; Type 1 Diabetes; Unconventional T Lymphocytes
Abstract
"Type I diabetes (T1D) is an autoimmune disease characterized by abnormal immune responses that attack insulin-producing cells in the pancreas. In addition to genetic susceptibility, alterations in intestinal microbiota composition - called dysbiosis - have been found in children with T1D. Invariant natural killer T (iNKT) and mucosa-associated invariant T (MAIT) cells, two populations of unconventional ""innate"" T cells, play protective functions during T1D. Recent studies have suggested that the gut microbiota modulates the development and function of these T cells, leading us to hypothesize that the dysbiosis that occurs in genetically susceptible individuals impacts their immunoregulatory functions which induces a breach in tolerance and development of T1D. To address this, we will reconstitute non-obese diabetic (NOD) germ-free (no microbiota) mice with a human microbiota from diabetic and non-diabetic children. We will analyze the phenotype of iNKT and MAIT cells from various tissues such as the pancreas and pancreatic lymph nodes using flow cytometry and advanced genomic approaches. To study the impact of the microbiota on their function, these cells will be stimulated both <em>in vivo</em> and <em>in vitro</em> to analyze their production of cytokines and cytotoxic mediators. We will assess early T1D onset by analyzing immune cell infiltration within the pancreas using flow cytometry and histology, and will monitor long-term disease progression through glycemia measurements and histological pancreatic islet examination. This project will provide a greater understanding of how the interaction between the microbiota and innate T cells influences disease development and progression, and pave the way towards new strategies to manipulate iNKT and MAIT cells to control or prevent T1D."
Competitiondate
201912
Approvedterm2
1 yr 0 mth
Pinamesdelim
Kuypers, Meggie
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~